Abstract Cardiovascular diseases lead to 31.5% of deaths globally, and particularly
myocardial infarction (MI) results in 7.4 million deaths per year. Diagnosis of MI and …

Nanoplasmonic devices have become a paradigm for biomolecular detection enabled by
enhanced light–matter interactions in the fields from biological and pharmaceutical research …

Biomarkers are unquestionable biological indicators for diagnosis and therapeutic
interventions providing appropriate classification of a wide range of health disorders and risk …

In resource-constrained countries, affordable methodologies for the detection of disease
biomarkers at ultralow concentrations can potentially improve the standard of living …

The detection and quantification of low-abundance molecular biomarkers in biological
samples is challenging. Here, we show that a plasmonic nanoscale construct serving as an …

Rapid, sensitive, simultaneous quantification of multiple biomarkers in point-of-care (POC)
settings could improve the diagnosis and management of sepsis, a common, potentially life …

Current metabolic analysis is far from ideal to engage clinics and needs rationally designed
materials and device. Here we developed a novel plasmonic chip for clinical metabolic …

In recent years, an increasing rate of mortality due to myocardial infarction (MI) has led to the
development of nanobased platforms, especially gold nanoparticles (AuNPs), as promising …

The sensitivity of localized surface plasmon resonance (LSPR) of metal nanostructures to
adsorbates lends itself to a powerful class of label-free biosensors. Optical properties of …

Diagnosis of lung cancer is performed using a plasmonic gold (pGOLD) chip through
multiplexed near‐infrared (NIR) detection of carcino‐embryonic antigen (CEA), Cyfra21‐1 …